News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cengent Therapeutics Signs Crystal Structure Determination Contract With Pierre Fabre


10/19/2005 5:12:37 PM

San Diego, CA (USA), Boulogne (France) - January 24, 2005 Cengent Therapeutics, a structure-guided drug discovery company, has established a collaboration agreement with the Research Institute of Pierre Fabre, the second largest French pharmaceutical company to access to Cengent’s X-ray crystallography services to advance the company’s internal drug discovery efforts. In this collaboration, Cengent will provide Pierre Fabre Research Institute with X-ray crystallography services, enabling researchers to view high-resolution structures of a human target in Oncology. Information obtained from X-ray crystallography structure of the target assist Pierre Fabre Research Institute in further structure-based lead design and optimization, enhancing the company’s ability to develop drug candidates.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES